These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 28385665)

  • 1. Dictating genomic destiny: Epigenetic regulation of pancreatic neuroendocrine tumours.
    Gundara JS; Jamal K; Kurzawinski T
    Mol Cell Endocrinol; 2018 Jul; 469():85-91. PubMed ID: 28385665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression.
    Di Domenico A; Pipinikas CP; Maire RS; Bräutigam K; Simillion C; Dettmer MS; Vassella E; Thirlwell C; Perren A; Marinoni I
    Commun Biol; 2020 Dec; 3(1):740. PubMed ID: 33288854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic drivers of neuroendocrine tumours (NET).
    Di Domenico A; Wiedmer T; Marinoni I; Perren A
    Endocr Relat Cancer; 2017 Sep; 24(9):R315-R334. PubMed ID: 28710117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoplasmic Reticulum Stress in Pancreatic Neuroendocrine Tumors is Linked to Clinicopathological Parameters and Possible Epigenetic Regulations.
    Klieser E; Illig R; Státtner S; Primavesi F; Jáger T; Swierczynski S; Kiesslich T; Kemmerling R; Bollmann C; Di Fazio P; Neureiter D
    Anticancer Res; 2015 Nov; 35(11):6127-36. PubMed ID: 26504039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium.
    Mafficini A; Scarpa A
    J Endocrinol; 2018 Mar; 236(3):R161-R167. PubMed ID: 29321190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors.
    Larsson C
    Neuroendocrinology; 2013; 97(1):19-25. PubMed ID: 22456267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors.
    Modali SD; Parekh VI; Kebebew E; Agarwal SK
    Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours.
    Pipinikas CP; Berner AM; Sposito T; Thirlwell C
    Endocr Relat Cancer; 2019 Aug; 26(9):R519-R544. PubMed ID: 31252410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine tumours: cracking the epigenetic code.
    Karpathakis A; Dibra H; Thirlwell C
    Endocr Relat Cancer; 2013 Jun; 20(3):R65-82. PubMed ID: 23429748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics and Epigenetics of Pancreatic Neuroendocrine Tumors and Pulmonary Carcinoids.
    Dreijerink KM; Derks JL; Cataldo I; Scarpa A; Valk GD; Speel EJ
    Front Horm Res; 2015; 44():115-38. PubMed ID: 26303708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic changes in gastroenteropancreatic neuroendocrine tumours.
    Mapelli P; Aboagye EO; Stebbing J; Sharma R
    Oncogene; 2015 Aug; 34(34):4439-47. PubMed ID: 25435371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future Directions in the Biology of Neuroendocrine Tumors.
    Halperin DM; Dasari A; Yao JC
    Pancreas; 2016 Jul; 45(6):783-5. PubMed ID: 27295529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours.
    Pipinikas CP; Dibra H; Karpathakis A; Feber A; Novelli M; Oukrif D; Fusai G; Valente R; Caplin M; Meyer T; Teschendorff A; Bell C; Morris TJ; Salomoni P; Luong TV; Davidson B; Beck S; Thirlwell C
    Endocr Relat Cancer; 2015 Jun; 22(3):L13-8. PubMed ID: 25900181
    [No Abstract]   [Full Text] [Related]  

  • 14. New Genetics and Genomic Data on Pancreatic Neuroendocrine Tumors: Implications for Diagnosis, Treatment, and Targeted Therapies.
    Schmitt AM; Marinoni I; Blank A; Perren A
    Endocr Pathol; 2016 Sep; 27(3):200-4. PubMed ID: 27456058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular mechanisms of development of pNET].
    Furukawa T
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():327-31. PubMed ID: 25857042
    [No Abstract]   [Full Text] [Related]  

  • 16. DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors.
    How-Kit A; Dejeux E; Dousset B; Renault V; Baudry M; Terris B; Tost J
    Epigenomics; 2015; 7(8):1245-58. PubMed ID: 26360914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC-Linked "Proliferative" miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors.
    Klieser E; Urbas R; Swierczynski S; Stättner S; Primavesi F; Jäger T; Mayr C; Kiesslich T; Fazio PD; Helm K; Neureiter D
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Molecular and Clinical Landscape of Pancreatic Neuroendocrine Tumors.
    Batukbhai BDO; De Jesus-Acosta A
    Pancreas; 2019 Jan; 48(1):9-21. PubMed ID: 30531241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epigenetic and transcriptional landscape of neuroendocrine prostate cancer.
    Davies A; Zoubeidi A; Selth LA
    Endocr Relat Cancer; 2020 Feb; 27(2):R35-R50. PubMed ID: 31804971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress and application of genetics and epigenetics in pancreatic neuroendocrine numors].
    Ren SQ; Zheng L; Yuan CH
    Zhonghua Yi Xue Za Zhi; 2019 Sep; 99(36):2801-2805. PubMed ID: 31550805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.